Filing Details
- Accession Number:
- 0001209191-19-059988
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-11 12:46:16
- Reporting Period:
- 2019-12-09
- Accepted Time:
- 2019-12-11 12:46:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
19411 | Magellan Health Inc | MGLN | Services-Hospitals (8060) | 581076937 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1647234 | Mostafa Kamal | 15950 North 76Th Street Suite 200 Scottsdale AZ 85260 | Ceo, Magellan Rx Management | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Common Stock, $0.01 Par Value | Acquisiton | 2019-12-09 | 16,666 | $60.55 | 19,459 | No | 4 | X | Direct | |
Ordinary Common Stock, $0.01 Par Value | Acquisiton | 2019-12-09 | 100 | $64.87 | 19,559 | No | 4 | X | Direct | |
Ordinary Common Stock, $0.01 Par Value | Disposition | 2019-12-09 | 16,766 | $78.72 | 2,793 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | X | Direct | |
No | 4 | X | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2019-12-09 | 16,666 | $0.00 | 16,666 | $60.55 |
Common Stock | Stock Option (right to buy) | Disposition | 2019-12-09 | 100 | $0.00 | 100 | $64.87 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2025-08-03 | No | 4 | X | Direct | |
7,206 | 2026-03-03 | No | 4 | X | Direct |
Footnotes
- This transaction was effectuated pursuant to a Rule 10b-5-1 Plan.
- The number of securities reported represents an aggregate number of shares sold in multiple open market transactions at prices ranging from $78.15 to $80.00, inclusive. The price reported represents the weighted average price. The Reporting Person undertakes to provide staff of the SEC, the issuer, or a stockholder of the issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
- All of the stock options in this tranche have vested in full.
- Not applicable.